Impact Factor 4.003 | CiteScore 4.0

More on impact ›


Front. Neurol., 24 September 2021 |

Editorial: Epidemiology and Genetics of Vestibular Disorders

  • 1Otology and Neurotology Group CTS495, Department of Genomic Medicine, GENYO - Centre for Genomics and Oncological Research - Pfizer/University of Granada/Junta de Andalucía, Parque Tecnologico de la Salud (PTS), Granada, Spain
  • 2Department of Otolaryngology, Instituto de Investigación Biosanitaria, ibs.GRANADA, Hospital Universitario Virgen de las Nieves, Granada, Spain
  • 3Division of Otolaryngology, Department of Surgery, Universidad de Granada, Granada, Spain
  • 4Sensorineural Pathology Programme, Centro de Investigacion Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain
  • 5Department of Otolaryngology - Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, United States
  • 6Institute for Medical Information Processing, Biometrics and Epidemiology, Ludwig-Maximilians-Universität München (LMU) Munich, Munich, Germany
  • 7German Center for Vertigo and Balance Disorders, University Hospital Munich, Ludwig-Maximilians-Universität München (LMU) Munich, Munich, Germany
  • 8Munich Centre of Health Sciences, Ludwig-Maximilians-Universität München (LMU) Munich, Munich, Germany
  • 9Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan

Editorial on the Research Topic
Epidemiology and Genetics of Vestibular Disorders

Vestibular disorders (VD) include a heterogeneous set of neuro-otological conditions. Peripheral and central VD such as vestibular migraine (VM) or Menière's disease (MD) are among the more frequently encountered disease entities, but there is also a large group of rare cerebellar disorders (13).

This issue of Frontiers in Neurology is dedicated to recent developments and new methodological findings in the epidemiology and genetics of VD. Of note, heritability has been largely ignored in VD as epidemiological evidence based on familial aggregation and twin studies are scarce (4, 5). Familial clustering suggests a genetic contribution in some VD, including VM, MD, and spinocerebellar and episodic ataxias (6, 7). Paz-Tamayo et al. show epidemiological evidence to support heritability in VM including familial aggregation and ethnic-specific differences in the occurrence of this condition.

However, a better characterization is needed to define syndromes and symptoms that overlap between individuals with a vestibular episodic syndrome and those with peripheral and central bilateral vestibular loss.

Precise history taking is the first and essential step for the diagnosis of vestibular disorders, and the systematic gathering of clinical information is particularly relevant in the primary care setting (Strobl et al.). The distribution of diagnoses in patients with VD is different in primary care and specialized neuro-otology clinics, and therefore they have different needs. Primary care professionals would benefit from training on maneuvers for repositioning otoliths, the diagnosis and treatment of different types of headaches, the identification of cardiovascular risk factors including orthostatic hypotension, and the appreciation of unwanted effects of some of the most commonly used drugs (Domínguez-Durán et al.) In an opinion paper, Maarsingh and van Vugt propose 10 practical vestibular tools for primary care physicians. In addition, machine learning techniques applied on large datasets have a huge potential to provide a decision support system for diagnosis and treatment in neuro-otology (Vivar et al.), including the classification of central and peripheral VD (8).

The assessment of disability is also a major issue in the elderly population and presbyvestibulopathy shows an important subjective perception of disability, particularly in women (Soto-Varela et al.). For this reason, co-morbidities should be carefully considered in patients with vestibular dysfunction (Malmström et al.), this approach being used to define clinical subgroups of patients (9, 10). Bilateral vestibulopathy (BVP) is a heterogeneous clinical condition characterized by a hypofunction of the vestibular nerves or labyrinths on both sides and quantitative assessment of the vestibulo-ocular reflex is needed to differentiate it from presbyvestibulopathy (11). In a retrospective study, Mancino-Moreira et al. classify patients into four clinical subgroups according to the symptoms: recurrent vertigo with BVP, rapidly progressive BVP, slowly progressive BVP, and slowly progressive BVP with ataxia.

Despite the huge progress in the definition and classification of vestibular disorders performed by the International Classification Committee, Dlugaiczyk et al. illustrate that there are still patients whose recurrent vestibular symptoms cannot be attributed to any of the recognized episodic vestibular syndromes, including MD (12), VM (13), benign paroxysmal positional vertigo (14), vestibular paroxysmia (15), orthostatic vertigo (16), or transient ischemic attacks (17). This category has been defined as recurrent vestibular symptoms not otherwise specified and it is composed of individuals with an incomplete phenotype not fulfilling the diagnostic criteria for MD or VM.

Research about the genetics of vestibular disorders in an emerging topic, including MD (1820), and this volume offers some outstanding pictures that contribute to a better understanding of neurotological disorders. Gu et al. combine RNAseq and data mining to define potential MD genes in the stria vascularis. Shew et al. report microRNA profiles in the perilymph and serum of patients with MD that may serve as potential biomarkers of the condition. The diagnosis and prognosis of MD is likely to be improved by the presence of endolymphatic sac (ES) hypoplasia, under the hypothesis that ES hypoplasia critically predisposes the inner ear to develop bilateral MD (Bächinger et al.).

Rujescu et al. report an allelic variant conferring susceptibility to vestibular neuritis, indirect evidence for an involvement of Herpes simplex virus in this condition. Mei et al. highlight the role of genetic sequencing to develop personalized medicine in VD. As an example, Oh et al. report the TRPM7 gene in a Korean family with four affected individuals with vestibular migraine as the first candidate gene for familial vestibular migraine by exome sequencing. Choi et al. also report MD-like symptoms in the 22q11.2 deletion syndrome, targeting the TBX1 gene. Moreover, epigenetic regulation by circular RNAs may explain susceptibility for intracranial aneurysms rupture (Huang et al.).

This is only the beginning. Genetic research in VD is still in its infancy. The development of cellular and animal models of vestibular disorders is needed to carry out functional validation of candidate genes obtained in human studies (21, 22). Gene replacement therapy can successfully repair auditory and vestibular hair cells and preserve organ function in genetic mouse models (23).

Author Contributions

JL-E wrote the original draft, assembled and incorporated comments from the co-authors, and crafted the final draft. All co-authors contributed to manuscript review and revision.


JL-E received research support from the Instituto de Salud Carlos III, European Regional Funds (Grant PI20/1126), Andalusian Family & Health Department (Grant PI027/2020), and the European Union (Horizon 2020, Grant Agreement 848261).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The handling editor declared shared affiliation with one of the authors, EG, at time of review.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


We thank our colleagues for devoting their time, expertise, and effort in producing valuable contributions that provide rigorous frameworks and innovative and critical insights. This book would not have been possible without their essential work. We also acknowledge the editorial team for their expert assistance and support in the production of this volume. Finally, with our utmost gratitude and profound respect, we want to dedicate this book to all patients with vestibular disorders and their families.


1. Requena T, Espinosa-Sanchez JM, Lopez-Escamez JA. Genetics of dizziness: cerebellar and vestibular disorders. Curr Opin Neurol. (2014) 27:98–104. doi: 10.1097/WCO.0000000000000053

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Frejo L, Giegling I, Teggi R, Lopez-Escamez JA, Rujescu D. Genetics of vestibular disorders: pathophysiological insights. J Neurol. (2016) 263:45–53. doi: 10.1007/s00415-015-7988-9

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Gallego-Martinez A, Espinosa-Sanchez JM, Lopez-Escamez JA. Genetic contribution to vestibular diseases. J Neurol. (2018) 265:29–34. doi: 10.1007/s00415-018-8842-7

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Cha YH, Kane MJ, Baloh RW. Familial clustering of migraine, episodic vertigo, and Ménière's disease. Otol Neurotol. (2008) 29:93–6. doi: 10.1097/mao.0b013e31815c2abb

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Requena T, Espinosa-Sanchez JM, Cabrera S, Trinidad G, Soto-Varela A, Santos-Perez S, et al. Familial clustering and genetic heterogeneity in Meniere's disease. Clin Genet. (2014) 85:245–52. doi: 10.1111/cge.12150

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Jen JC, Wan J. Episodic ataxias. Handb Clin Neurol. (2018) 155:205–15. doi: 10.1016/B978-0-444-64189-2.00013-5

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Manto M, Gandini J, Feil K, Strupp M. Cerebellar ataxias: an update. Curr Opin Neurol. (2020) 33:150–60. doi: 10.1097/WCO.0000000000000774

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Ahmadi SA, Vivar G, Navab N, Möhwald K, Maier A, Hadzhikolev H, et al. Modern machine-learning can support diagnostic differentiation of central and peripheral acute vestibular disorders. J Neurol. (2020) 267 (Suppl. 1):143–52. doi: 10.1007/s00415-020-09931-z

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Frejo L, Martin-Sanz E, Teggi R, Trinidad G, Soto-Varela A, Santos-Perez S, et al. Extended phenotype and clinical subgroups in unilateral Meniere disease: a cross-sectional study with cluster analysis. Clin Otolaryngol. (2017) 42:1172–80. doi: 10.1111/coa.12844

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Frejo L, Soto-Varela A, Santos-Perez S, Aran I, Batuecas-Caletrio A, Perez-Guillen V, et al. Clinical subgroups in bilateral Meniere disease. Front Neurol. (2016) 7:182. doi: 10.3389/fneur.2016.00182

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Strupp M, Kim JS, Murofushi T, Straumann D, Jen JC, Rosengren SM, et al. Bilateral vestibulopathy: diagnostic criteria Consensus document of the Classification Committee of the Bárány Society. J Vestib Res. (2017) 27:177–89. doi: 10.3233/VES-170619

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, et al. Diagnostic criteria for Menière's disease. J Vestib Res. (2015) 25:1–7. doi: 10.3233/VES-150549

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. (2012) 22:167–72. doi: 10.3233/VES-2012-0453

PubMed Abstract | CrossRef Full Text | Google Scholar

14. von Brevern M, Bertholon P, Brandt T, Fife T, Imai T, Nuti D, et al. Benign paroxysmal positional vertigo: diagnostic criteria. J Vestib Res. (2015) 25:105–17. doi: 10.3233/VES-150553

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Strupp M, Lopez-Escamez JA, Kim JS, Straumann D, Jen JC, Carey J, et al. Vestibular paroxysmia: diagnostic criteria. J Vestib Res. (2016) 26:409–15. doi: 10.3233/VES-160589

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Kim HA, Bisdorff A, Bronstein AM, Lempert T, Rossi-Izquierdo M, Staab JP, et al. Hemodynamic orthostatic dizziness/vertigo: diagnostic criteria. J Vestib Res. (2019) 29:45–56. doi: 10.3233/VES-190655

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. (2009) 40:2276–93. doi: 10.1161/STROKEAHA.108.192218

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Gallego-Martinez A, Requena T, Roman-Naranjo P, Lopez-Escamez JA. Excess of rare Missence variants in hearing loss genes in sporadic Meniere disease. Front Genet. (2019) 10:76. doi: 10.3389/fgene.2019.00076

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Gallego-Martinez A, Requena T, Roman-Naranjo P, May P, Lopez-Escamez JA. Enrichment of damaging missense variants in genes related with axonal guidance signalling in sporadic Meniere's disease. J Med Genet. (2020) 57:82–88. doi: 10.1136/jmedgenet-2019-106159

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Roman-Naranjo P, Gallego-Martinez A, Soto-Varela A, et al. Burden of rare variants in the OTOG gene in familial Meniere's disease. Ear Hear. (2020) 41:1598–605. doi: 10.1097/AUD.0000000000000878

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Vona B, Doll J, Hofrichter MAH, Haaf T, Varshney GK. Small fish, big prospects: using zebrafish to unravel the mechanisms of hereditary hearing loss. Hear Res. (2020) 397:107906. doi: 10.1016/j.heares.2020.107906

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Hu CJ, Lu YC, Yang TH, Chan YH, Tsai CY, Yu IS. Toward the pathogenicity of the SLC26A4 p.C565Y variant using a genetically driven mouse model. Int J Mol Sci. (2021) 22:2789. doi: 10.3390/ijms22062789

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Sayyid ZN, Kim GS, Cheng AG. Molecular therapy for genetic and degenerative vestibular disorders. Curr Opin Otolaryngol Head Neck Surg. (2018) 26:307–11. doi: 10.1097/MOO.0000000000000477

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Meniere disease, vestibular migraine, heritability, exome sequencing, RNA seq, familial aggregation

Citation: Lopez-Escamez JA, Cheng AG, Grill E and Liu T-C (2021) Editorial: Epidemiology and Genetics of Vestibular Disorders. Front. Neurol. 12:743379. doi: 10.3389/fneur.2021.743379

Received: 18 July 2021; Accepted: 16 August 2021;
Published: 24 September 2021.

Edited by:

Michael Strupp, Ludwig Maximilian University of Munich, Germany

Reviewed by:

Jorge Kattah, University of Illinois at Chicago, United States
Nese Celebisoy, Ege University, Turkey
Maurizio Versino, ASST Settelaghi, Italy

Copyright © 2021 Lopez-Escamez, Cheng, Grill and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jose A. Lopez-Escamez,